您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2015, Vol. 53 ›› Issue (1): 73-76.doi: 10.6040/j.issn.1671-7554.0.2014.600

• 临床医学 • 上一篇    下一篇

肾癌尿沉渣中人端粒酶逆转录酶基因启动子区甲基化检测的临床意义

任洪波, 刘海南, 刘承, 颜克强, 夏传友, 范医东   

  1. 山东大学齐鲁医院泌尿外科, 山东 济南 250012
  • 收稿日期:2014-09-11 修回日期:2014-11-25 发布日期:2015-01-10
  • 通讯作者: 范医东。E-mail:fanyd@sdu.edu.cn E-mail:fanyd@sdu.edu.cn
  • 基金资助:
    国家自然科学基金(81472395)

Clinical significance of human telomerase reverse transcriptase gene methylation status in urine sediments of renal cell carcinoma

REN Hongbo, LIU Hainan, LIU Cheng, YAN Keqiang, XIA Chuanyou, FAN Yidong   

  1. Department of Urology, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China
  • Received:2014-09-11 Revised:2014-11-25 Published:2015-01-10

摘要: 目的 探讨人端粒酶逆转录酶(hTERT)启动子区在肾癌患者尿沉渣中DNA甲基化状态及临床意义。方法 提取76例肾癌(肾癌组)和38例非肾癌(对照组)患者术前尿沉渣中的DNA,经亚硫酸氢钠修饰后,应用甲基化特异性PCR(MSP)方法对DNA进行扩增,将MSP产物进行凝胶电泳观察分析甲基化情况。结果 肾癌组患者hTERT启动子区高甲基化发生率明显高于对照组(P<0.05), 但hTERT启动子区高甲基化与性别、年龄、肿瘤大小、肿瘤分期无统计学关联(P>0.05)。结论 尿沉渣中hTERT启动子区甲基化与肾癌发生相关,并且其作为一种无创性检测有助于肾癌的临床诊断。

关键词: 尿沉渣, 甲基化, 人端粒酶逆转录酶, 肾肿瘤

Abstract: Objective To elucidate the methylation status of human telomerase reverse transcriptase (hTERT) promoter in urine sediments obtained from preoperative patients with renal cell carcinoma (RCC). Methods Genomic DNA was extracted from urine sediments of 76 RCC patients (RCC group) and 38 non-renal cell carcinoma patients (control group). Specimen DNA was modified with sodium bisulfite, methylation specific PCR (MSP) was carried out, and agar gel electrophoresis was performed to analyze the methylation status of hTERT gene. Results The rate of hTERT hypermethylation in RCC group was obviously higher than that in control group (P< 0.05). But no statistical correlation was observed between hTERT promoter methylation and gender, age, tumor size or clinical stage (P>0.05). Conclusion hTERT promoter in urine sediment of renal cell carcinoma patients is highly methylated, and as a noninvasive investigation, it might be useful in the clinical diagnosis of renal cell carcinoma.

Key words: Renal neoplasms, Methylation, Human telomerase reverse transcriptase, Urine sediments

中图分类号: 

  • R737.11
[1] Moch H, Sriqiey J, Delahent B, et al. Biomarkers in renal cancer[J]. Virchows Arch, 2014, 464(3): 359-365.
[2] Liu L, Saldanha SN, Pate MS, et al. Epigenetic regulation of human telomerase reverse transcriptase promoter activity during cellular differentiation[J]. Genes Chromosomes Cancer, 2004, 41(1): 26-37.
[3] Fan Y, Liu Z, Fang X, et al. Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues[J]. Clin Cancer Res, 2005, 11(12): 4331-4337.
[4] Guilleret I, Yan P, Grange F, et al. Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity[J]. Int Cancer, 2002, 101(4): 335-341.
[5] Costa VL, Henrique R, Danielsen SA, et al. TCF21 and PCDH17 methylation An innovative panel of biomarkers for a simultaneous detection of urological cancers[J]. Epigenetics, 2011, 6(9): 1120-1130.
[6] Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual[M]. 7th ed. New York: Springer Verlag, 2009:547-560.
[7] Holmes EE, Jung M, Meller S, et al. Performance evaluation of kits for bisulfite-conversion of DNA from tissues, cell lines, FFPE tissues, aspirates, lavages, effusions, plasma, serum, and urine[J]. PLoS One, 2014, 9(4): e93933.doi:10.1371/journal. pone. 0093933.
[8] 迟元卫, 陈健, 刘亮, 等. 结肠癌中hTERT和P53蛋白表达及临床意义[J]. 山东大学学报: 医学版, 2011, 49(4): 115-117. CHI Yuanwei, CHEN Jian, LIU Liang, et al. Expressions of hTERT and P53 and significance in colorectal carcinoma[J]. Journal of Shandong University: Health Sciences, 2011, 49(4): 115-117.
[9] Ruland V, Hartung S, Kordes U, et al. Methylation of the hTERT promoter is frequent in choroid plexus tumors but not of independent prognostic value[J]. J Neurooncol, 2014, 119(1): 215-216.
[10] Bougel S, Lhermitte B, Gallagher G, et al. Methylation of the hTERT promoter: a novel cancer biomarker for leptomeningeal metastasis detection in cerebrospinal fluids[J]. Clin Cancer Res, 2013, 19(8): 2216-2223.
[11] de Wilde J, Kooter JM, Overmeer RM, et al. hTERT promoter activity and CpG methylation in HPV-induced carcinogenesis[J]. BMC Cancer, 2010, 10:271.doi: 10.1186/1471-2407- 10-271.
[12] 吴芃, 郑少, 斌左翼, 等. hTERT在肾癌中的表达及临床意义[J]. 南方医科大学学报, 2008, 28(2): 272-274. WU Peng, ZHENG Shao, BIN Zuoyi, et al. Expression of human telomerase reverse transcriptase in renal cell carcinoma and its clinical significance[J]. Journal of Southern Medical University, 2008, 28(2): 272-274.
[13] Ho CL , Tzai TS, Chen JC, et al. The molecular signature for urothelial carcinoma of the upper urinary tract[J]. J Urol, 2008, 179(3): 1155-1159.
[14] Castelo-Branco P, Choufani S, Mack S, et al. Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study[J]. Lancet Oncol, 2013, 14(6): 534-542.
[15] Bougel S, Lhermitte B, Gallagher G, et al. Methylation of the hTERT promoter: a novel cancer biomarker for leptomeningeal metastasis detection in cerebrospinal fluids[J]. Clin Cancer Res, 2013, 19(8): 2216-2223.
[16] Zhao Y, Zhou H, Ma K, et al. Abnormal methylation of seven genes and their associations with clinical characteristics in early stage non-small cell lung cancer[J]. Oncol Lett, 2013, 5(4): 1211-1218.
[17] Hoque MO, Begum S, Topaloglu O, et al. Quantitative detection of promoter hypermethylation of patients with renal cancer multiple genes in the tumor, urine, and serum DNA of patients with renal cancer[J]. Cancer Res, 2004, 64(15): 5511-5517.
[1] 陈琦,李佳琪,郭智彬,贾惊宇,何林生. 环氧化酶-2基因启动子区甲基化水平在子宫内膜异位症中的作用[J]. 山东大学学报(医学版), 2017, 55(1): 44-48.
[2] 周雪,王燕蓉,田龙,马良宏,颜贝,田稼,张帆,周岳,王红燕. 冷冻复苏过程对人精子印记基因SNRPN和GRB10DNA甲基化及表达的影响[J]. 山东大学学报(医学版), 2017, 55(1): 54-59.
[3] 杨娟, 邱宗建, 宋强. 辛伐他汀对急性髓系白血病NB4细胞株DNA甲基转移酶的影响[J]. 山东大学学报(医学版), 2015, 53(6): 28-32.
[4] 任巨超, 李明宝, 刘焕银, 房志卿, 闫磊, 徐忠华. 腹腔镜超声在肾部分切除术治疗肾门旁中央型小肾癌中的临床价值[J]. 山东大学学报(医学版), 2015, 53(3): 77-80.
[5] 宗丽菊, 张友忠, 王颉, 吴淑霞, 刘洪丽, 张璐. 四甲基吡啶卟啉-光动力疗法对人宫颈永生化上皮H8细胞的作用[J]. 山东大学学报(医学版), 2015, 53(1): 21-26.
[6] 王颉, 张友忠, 冯进波, 刘洪丽, 宗丽菊. 慢病毒介导的hTERT-shRNA联合光动力治疗对宫颈癌细胞SiHa的影响[J]. 山东大学学报(医学版), 2015, 53(1): 27-33.
[7] 李洪丽,王焱,徐文伟,董琳,郭燕,朱传升,毕可红. K562细胞TMS1基因去甲基化后NF-κB表达的变化[J]. 山东大学学报(医学版), 2014, 52(4): 62-66.
[8] 卢倩倩,梁婧,刘晓琳,李岩. 异体CD3AK细胞对人肾癌SCID小鼠移植瘤抑制作用的观察[J]. 山东大学学报(医学版), 2014, 52(2): 33-37.
[9] 王昌1,李丽2,董彩莉3,刘承1,王坤1,刘海南1,范医东1. Xp11.2易位相关性肾细胞癌的临床特点[J]. 山东大学学报(医学版), 2013, 51(7): 79-83.
[10] 张斌1,陈杰2,刘雁3,张士宝2,刘双庆2,刘波2,王全颖4,杨广笑4,刘庆勇2. 分泌表达肾癌抑制融合肽的重组腺伴随病毒对肾癌移植瘤的疗效[J]. 山东大学学报(医学版), 2013, 51(5): 33-36.
[11] 范海燕,张慧景,郭占军,李胜棉. 肝细胞癌患者癌组织中RASSF1A和WIF-1基因甲基化的临床意义[J]. 山东大学学报(医学版), 2013, 51(5): 89-93.
[12] 徐佳, 宋强 . 骨髓增生异常综合征患者RASSF1A基因启动子区甲基化及基因表达的缺失[J]. 山东大学学报(医学版), 2013, 51(2): 65-69.
[13] 侯贝贝,王妍,张娟,梁晓辉,李劲松. 软骨肉瘤WIF-1基因甲基化及Wnt-5a蛋白表达的临床病理意义[J]. 山东大学学报(医学版), 2013, 51(2): 70-74.
[14] 陈海燕,姚树哲,张晓莹,张建平,张翠娟,张廷国. SOCS-3和3-OST-2基因甲基化在子宫内膜癌中的作用及其临床病理意义[J]. 山东大学学报(医学版), 2013, 51(06): 75-80.
[15] 卢国栋,袁明振,俎树禄,赵升田. SPOP蛋白在肾透明细胞癌中的表达[J]. 山东大学学报(医学版), 2012, 50(7): 74-77.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!